Literature DB >> 12664756

Hospital at home services for acute exacerbation of chronic obstructive pulmonary disease: a survey of British practice.

M K Johnson1, U Flanigan, J Fuld, A Irwin, C Stewart, R D Stevenson.   

Abstract

OBJECTIVES: To identify the prevalence of and attitudes towards hospital at home services for acute exacerbation of chronic obstructive pulmonary disease (COPD) in Great Britain. To identify the models of service in existence, in particular staff numbers and the workload experienced.
DESIGN: A postal survey was used to locate existing schemes. Telephone interviews were conducted with each of the hospital at home services identified. SUBJECTS &
SETTING: A questionnaire was sent to one consultant in each of 223 respiratory departments in Great Britain. Thirty six departments were subsequently contacted by telephone. OUTCOME MEASURES: Awareness and prevalence of hospital at home services. Perceived problems with starting a service. Details of organisation of existing services.
RESULTS: We received 186 replies to the postal questionnaire. Of these respiratory departments, 179 (96%) were aware of hospital at home services for acute exacerbation of COPD and, in November 1999, 30 (16%) were running such a service. Difficulty in obtaining funding was the main reason for not setting up a service rather than lack of evidence of benefit or unsuitability of local circumstances. Median staffing level was two nurses (range one to six) looking after a median number of new patients of five per week (range 0.5 to 12). There was wide variation in the organisation of services.
CONCLUSIONS: Despite lack of objective evidence of effectiveness, there was a high level of awareness of and interest in starting hospital at home services for acute exacerbation of COPD in British respiratory departments when assessed in November 1999.

Entities:  

Mesh:

Year:  2001        PMID: 12664756

Source DB:  PubMed          Journal:  Health Bull (Edinb)        ISSN: 0374-8014


  6 in total

1.  Intermediate care--Hospital-at-Home in chronic obstructive pulmonary disease: British Thoracic Society guideline.

Authors: 
Journal:  Thorax       Date:  2006-11-07       Impact factor: 9.139

Review 2.  Hospital at home for patients with acute exacerbations of chronic obstructive pulmonary disease: systematic review of evidence.

Authors:  Felix S F Ram; Jadwiga A Wedzicha; John Wright; Michael Greenstone
Journal:  BMJ       Date:  2004-07-08

3.  Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial.

Authors:  Cecile M A Utens; Lucas M A Goossens; Frank W J M Smeenk; Onno C P van Schayck; Walter van Litsenburg; Annet Janssen; Monique van Vliet; Wiel Seezink; Dirk R A J Demunck; Brigitte van de Pas; Peter J de Bruijn; Anouschka van der Pouw; Jeroen M A M Retera; Petra de Laat-Bierings; Loes van Eijsden; Maria Braken; Riet Eijsermans; Maureen P M H Rutten-van Mölken
Journal:  BMC Public Health       Date:  2010-10-18       Impact factor: 3.295

4.  Evaluation of health care providers' role transition and satisfaction in hospital-at-home for chronic obstructive pulmonary disease exacerbations: a survey study.

Authors:  Cecile M A Utens; Lucas M A Goossens; Onno C P van Schayck; Maureen P H M Rutten-Vanmölken; Maria W Braken; Loes M G A van Eijsden; Frank W J M Smeenk
Journal:  BMC Health Serv Res       Date:  2013-09-27       Impact factor: 2.655

Review 5.  Immediate and early discharge for patients with exacerbations of chronic obstructive pulmonary disease: is there a role in "real life"?

Authors:  Mahendran Chetty; Mel MacKenzie; Graham Douglas; Graeme P Currie
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

6.  Patient, informal caregiver and care provider acceptance of a hospital in the home program in Ontario, Canada.

Authors:  Jacques Lemelin; William E Hogg; Simone Dahrouge; Catherine Deri Armstrong; Carmel M Martin; Wei Zhang; Jo-Anne Dusseault; Joy Parsons-Nicota; Raphael Saginur; Gary Viner
Journal:  BMC Health Serv Res       Date:  2007-08-17       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.